2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Dapagliflozin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-26S9723
Home | Market Reports | Health| Health Conditions
Global Dapagliflozin API Market Insights Forecast to 2028
BUY CHAPTERS

Dapagliflozin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-26S9723
Report
November 2024
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dapagliflozin API - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Dapagliflozin API - Market

Dapagliflozin API - Market

Dapagliflozin is a medication used to treat type 2 diabetes and, with certain restrictions, type 1 diabetes.
The global market for Dapagliflozin API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dapagliflozin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dapagliflozin API by region & country, by Type, and by Application.
The Dapagliflozin API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dapagliflozin API.
Market Segmentation

Scope of Dapagliflozin API - Market Report

Report Metric Details
Report Name Dapagliflozin API - Market
CAGR 5%
Segment by Type:
  • ≥99.0%
  • ≥98.0%
Segment by Application
  • Tablet
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sun Pharmaceutical Industries Ltd., Metrochem API Pvt Ltd, Polpharma, Dr. Reddy’s Laboratories Ltd., CIC, Honour Lab Limited, SGMR Pharmaceuticals Pvt Ltd., Kopran, Morepen, SKVen Technologies Pvt. Ltd, Danesh Kimia Pharmed Co., Boryung Pharmaceutical, Tecoland, Zhejiang Tuopu Pharmaceutical Co., Ltd., Shanghai Haoyuan Chemexpress Co., Ltd., Cangzhou Enke Pharma Tech Co.,ltd., Beijing Ditai Medicine Technology Co., LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dapagliflozin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Dapagliflozin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Dapagliflozin API in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Dapagliflozin API - Market report?

Ans: The main players in the Dapagliflozin API - Market are Sun Pharmaceutical Industries Ltd., Metrochem API Pvt Ltd, Polpharma, Dr. Reddy’s Laboratories Ltd., CIC, Honour Lab Limited, SGMR Pharmaceuticals Pvt Ltd., Kopran, Morepen, SKVen Technologies Pvt. Ltd, Danesh Kimia Pharmed Co., Boryung Pharmaceutical, Tecoland, Zhejiang Tuopu Pharmaceutical Co., Ltd., Shanghai Haoyuan Chemexpress Co., Ltd., Cangzhou Enke Pharma Tech Co.,ltd., Beijing Ditai Medicine Technology Co., LTD

What are the Application segmentation covered in the Dapagliflozin API - Market report?

Ans: The Applications covered in the Dapagliflozin API - Market report are Tablet, Others

What are the Type segmentation covered in the Dapagliflozin API - Market report?

Ans: The Types covered in the Dapagliflozin API - Market report are ≥99.0%, ≥98.0%

Recommended Reports

Diabetes APIs

Diabetes Therapeutics

General API Markets

1 Market Overview
1.1 Dapagliflozin API Product Introduction
1.2 Global Dapagliflozin API Market Size Forecast
1.2.1 Global Dapagliflozin API Sales Value (2019-2030)
1.2.2 Global Dapagliflozin API Sales Volume (2019-2030)
1.2.3 Global Dapagliflozin API Sales Price (2019-2030)
1.3 Dapagliflozin API Market Trends & Drivers
1.3.1 Dapagliflozin API Industry Trends
1.3.2 Dapagliflozin API Market Drivers & Opportunity
1.3.3 Dapagliflozin API Market Challenges
1.3.4 Dapagliflozin API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dapagliflozin API Players Revenue Ranking (2023)
2.2 Global Dapagliflozin API Revenue by Company (2019-2024)
2.3 Global Dapagliflozin API Players Sales Volume Ranking (2023)
2.4 Global Dapagliflozin API Sales Volume by Company Players (2019-2024)
2.5 Global Dapagliflozin API Average Price by Company (2019-2024)
2.6 Key Manufacturers Dapagliflozin API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dapagliflozin API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dapagliflozin API
2.9 Dapagliflozin API Market Competitive Analysis
2.9.1 Dapagliflozin API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dapagliflozin API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dapagliflozin API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ≥99.0%
3.1.2 ≥98.0%
3.2 Global Dapagliflozin API Sales Value by Type
3.2.1 Global Dapagliflozin API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dapagliflozin API Sales Value, by Type (2019-2030)
3.2.3 Global Dapagliflozin API Sales Value, by Type (%) (2019-2030)
3.3 Global Dapagliflozin API Sales Volume by Type
3.3.1 Global Dapagliflozin API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dapagliflozin API Sales Volume, by Type (2019-2030)
3.3.3 Global Dapagliflozin API Sales Volume, by Type (%) (2019-2030)
3.4 Global Dapagliflozin API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Others
4.2 Global Dapagliflozin API Sales Value by Application
4.2.1 Global Dapagliflozin API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dapagliflozin API Sales Value, by Application (2019-2030)
4.2.3 Global Dapagliflozin API Sales Value, by Application (%) (2019-2030)
4.3 Global Dapagliflozin API Sales Volume by Application
4.3.1 Global Dapagliflozin API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dapagliflozin API Sales Volume, by Application (2019-2030)
4.3.3 Global Dapagliflozin API Sales Volume, by Application (%) (2019-2030)
4.4 Global Dapagliflozin API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dapagliflozin API Sales Value by Region
5.1.1 Global Dapagliflozin API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dapagliflozin API Sales Value by Region (2019-2024)
5.1.3 Global Dapagliflozin API Sales Value by Region (2025-2030)
5.1.4 Global Dapagliflozin API Sales Value by Region (%), (2019-2030)
5.2 Global Dapagliflozin API Sales Volume by Region
5.2.1 Global Dapagliflozin API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dapagliflozin API Sales Volume by Region (2019-2024)
5.2.3 Global Dapagliflozin API Sales Volume by Region (2025-2030)
5.2.4 Global Dapagliflozin API Sales Volume by Region (%), (2019-2030)
5.3 Global Dapagliflozin API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dapagliflozin API Sales Value, 2019-2030
5.4.2 North America Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dapagliflozin API Sales Value, 2019-2030
5.5.2 Europe Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dapagliflozin API Sales Value, 2019-2030
5.6.2 Asia Pacific Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dapagliflozin API Sales Value, 2019-2030
5.7.2 South America Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dapagliflozin API Sales Value, 2019-2030
5.8.2 Middle East & Africa Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dapagliflozin API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dapagliflozin API Sales Value
6.2.1 Key Countries/Regions Dapagliflozin API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dapagliflozin API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dapagliflozin API Sales Value, 2019-2030
6.3.2 United States Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dapagliflozin API Sales Value, 2019-2030
6.4.2 Europe Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dapagliflozin API Sales Value, 2019-2030
6.5.2 China Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dapagliflozin API Sales Value, 2019-2030
6.6.2 Japan Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dapagliflozin API Sales Value, 2019-2030
6.7.2 South Korea Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dapagliflozin API Sales Value, 2019-2030
6.8.2 Southeast Asia Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dapagliflozin API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dapagliflozin API Sales Value, 2019-2030
6.9.2 India Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dapagliflozin API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sun Pharmaceutical Industries Ltd.
7.1.1 Sun Pharmaceutical Industries Ltd. Company Information
7.1.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.1.3 Sun Pharmaceutical Industries Ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sun Pharmaceutical Industries Ltd. Dapagliflozin API Product Offerings
7.1.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.2 Metrochem API Pvt Ltd
7.2.1 Metrochem API Pvt Ltd Company Information
7.2.2 Metrochem API Pvt Ltd Introduction and Business Overview
7.2.3 Metrochem API Pvt Ltd Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Metrochem API Pvt Ltd Dapagliflozin API Product Offerings
7.2.5 Metrochem API Pvt Ltd Recent Development
7.3 Polpharma
7.3.1 Polpharma Company Information
7.3.2 Polpharma Introduction and Business Overview
7.3.3 Polpharma Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Polpharma Dapagliflozin API Product Offerings
7.3.5 Polpharma Recent Development
7.4 Dr. Reddy’s Laboratories Ltd.
7.4.1 Dr. Reddy’s Laboratories Ltd. Company Information
7.4.2 Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
7.4.3 Dr. Reddy’s Laboratories Ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Dr. Reddy’s Laboratories Ltd. Dapagliflozin API Product Offerings
7.4.5 Dr. Reddy’s Laboratories Ltd. Recent Development
7.5 CIC
7.5.1 CIC Company Information
7.5.2 CIC Introduction and Business Overview
7.5.3 CIC Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CIC Dapagliflozin API Product Offerings
7.5.5 CIC Recent Development
7.6 Honour Lab Limited
7.6.1 Honour Lab Limited Company Information
7.6.2 Honour Lab Limited Introduction and Business Overview
7.6.3 Honour Lab Limited Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Honour Lab Limited Dapagliflozin API Product Offerings
7.6.5 Honour Lab Limited Recent Development
7.7 SGMR Pharmaceuticals Pvt Ltd.
7.7.1 SGMR Pharmaceuticals Pvt Ltd. Company Information
7.7.2 SGMR Pharmaceuticals Pvt Ltd. Introduction and Business Overview
7.7.3 SGMR Pharmaceuticals Pvt Ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 SGMR Pharmaceuticals Pvt Ltd. Dapagliflozin API Product Offerings
7.7.5 SGMR Pharmaceuticals Pvt Ltd. Recent Development
7.8 Kopran
7.8.1 Kopran Company Information
7.8.2 Kopran Introduction and Business Overview
7.8.3 Kopran Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Kopran Dapagliflozin API Product Offerings
7.8.5 Kopran Recent Development
7.9 Morepen
7.9.1 Morepen Company Information
7.9.2 Morepen Introduction and Business Overview
7.9.3 Morepen Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Morepen Dapagliflozin API Product Offerings
7.9.5 Morepen Recent Development
7.10 SKVen Technologies Pvt. Ltd
7.10.1 SKVen Technologies Pvt. Ltd Company Information
7.10.2 SKVen Technologies Pvt. Ltd Introduction and Business Overview
7.10.3 SKVen Technologies Pvt. Ltd Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 SKVen Technologies Pvt. Ltd Dapagliflozin API Product Offerings
7.10.5 SKVen Technologies Pvt. Ltd Recent Development
7.11 Danesh Kimia Pharmed Co.
7.11.1 Danesh Kimia Pharmed Co. Company Information
7.11.2 Danesh Kimia Pharmed Co. Introduction and Business Overview
7.11.3 Danesh Kimia Pharmed Co. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Danesh Kimia Pharmed Co. Dapagliflozin API Product Offerings
7.11.5 Danesh Kimia Pharmed Co. Recent Development
7.12 Boryung Pharmaceutical
7.12.1 Boryung Pharmaceutical Company Information
7.12.2 Boryung Pharmaceutical Introduction and Business Overview
7.12.3 Boryung Pharmaceutical Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Boryung Pharmaceutical Dapagliflozin API Product Offerings
7.12.5 Boryung Pharmaceutical Recent Development
7.13 Tecoland
7.13.1 Tecoland Company Information
7.13.2 Tecoland Introduction and Business Overview
7.13.3 Tecoland Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Tecoland Dapagliflozin API Product Offerings
7.13.5 Tecoland Recent Development
7.14 Zhejiang Tuopu Pharmaceutical Co., Ltd.
7.14.1 Zhejiang Tuopu Pharmaceutical Co., Ltd. Company Information
7.14.2 Zhejiang Tuopu Pharmaceutical Co., Ltd. Introduction and Business Overview
7.14.3 Zhejiang Tuopu Pharmaceutical Co., Ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Zhejiang Tuopu Pharmaceutical Co., Ltd. Dapagliflozin API Product Offerings
7.14.5 Zhejiang Tuopu Pharmaceutical Co., Ltd. Recent Development
7.15 Shanghai Haoyuan Chemexpress Co., Ltd.
7.15.1 Shanghai Haoyuan Chemexpress Co., Ltd. Company Information
7.15.2 Shanghai Haoyuan Chemexpress Co., Ltd. Introduction and Business Overview
7.15.3 Shanghai Haoyuan Chemexpress Co., Ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Shanghai Haoyuan Chemexpress Co., Ltd. Dapagliflozin API Product Offerings
7.15.5 Shanghai Haoyuan Chemexpress Co., Ltd. Recent Development
7.16 Cangzhou Enke Pharma Tech Co.,ltd.
7.16.1 Cangzhou Enke Pharma Tech Co.,ltd. Company Information
7.16.2 Cangzhou Enke Pharma Tech Co.,ltd. Introduction and Business Overview
7.16.3 Cangzhou Enke Pharma Tech Co.,ltd. Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Cangzhou Enke Pharma Tech Co.,ltd. Dapagliflozin API Product Offerings
7.16.5 Cangzhou Enke Pharma Tech Co.,ltd. Recent Development
7.17 Beijing Ditai Medicine Technology Co., LTD
7.17.1 Beijing Ditai Medicine Technology Co., LTD Company Information
7.17.2 Beijing Ditai Medicine Technology Co., LTD Introduction and Business Overview
7.17.3 Beijing Ditai Medicine Technology Co., LTD Dapagliflozin API Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Beijing Ditai Medicine Technology Co., LTD Dapagliflozin API Product Offerings
7.17.5 Beijing Ditai Medicine Technology Co., LTD Recent Development
8 Industry Chain Analysis
8.1 Dapagliflozin API Industrial Chain
8.2 Dapagliflozin API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dapagliflozin API Sales Model
8.5.2 Sales Channel
8.5.3 Dapagliflozin API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dapagliflozin API Market Trends
    Table 2. Dapagliflozin API Market Drivers & Opportunity
    Table 3. Dapagliflozin API Market Challenges
    Table 4. Dapagliflozin API Market Restraints
    Table 5. Global Dapagliflozin API Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dapagliflozin API Revenue Market Share by Company (2019-2024)
    Table 7. Global Dapagliflozin API Sales Volume by Company (2019-2024) & (Kg)
    Table 8. Global Dapagliflozin API Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dapagliflozin API Price by Company (2019-2024) & (US$/Kg)
    Table 10. Key Manufacturers Dapagliflozin API Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dapagliflozin API Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dapagliflozin API
    Table 13. Global Dapagliflozin API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dapagliflozin API as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dapagliflozin API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dapagliflozin API Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dapagliflozin API Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dapagliflozin API Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dapagliflozin API Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dapagliflozin API Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)
    Table 22. Global Dapagliflozin API Sales Volume by Type (2019-2024) & (Kg)
    Table 23. Global Dapagliflozin API Sales Volume by Type (2025-2030) & (Kg)
    Table 24. Global Dapagliflozin API Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dapagliflozin API Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dapagliflozin API Price by Type (2019-2024) & (US$/Kg)
    Table 27. Global Dapagliflozin API Price by Type (2025-2030) & (US$/Kg)
    Table 28. Global Dapagliflozin API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dapagliflozin API Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dapagliflozin API Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dapagliflozin API Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dapagliflozin API Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dapagliflozin API Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)
    Table 34. Global Dapagliflozin API Sales Volume by Application (2019-2024) & (Kg)
    Table 35. Global Dapagliflozin API Sales Volume by Application (2025-2030) & (Kg)
    Table 36. Global Dapagliflozin API Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dapagliflozin API Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dapagliflozin API Price by Application (2019-2024) & (US$/Kg)
    Table 39. Global Dapagliflozin API Price by Application (2025-2030) & (US$/Kg)
    Table 40. Global Dapagliflozin API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dapagliflozin API Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dapagliflozin API Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dapagliflozin API Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dapagliflozin API Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dapagliflozin API Sales Volume by Region (Kg): 2019 VS 2023 VS 2030
    Table 46. Global Dapagliflozin API Sales Volume by Region (2019-2024) & (Kg)
    Table 47. Global Dapagliflozin API Sales Volume by Region (2025-2030) & (Kg)
    Table 48. Global Dapagliflozin API Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dapagliflozin API Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dapagliflozin API Average Price by Region (2019-2024) & (US$/Kg)
    Table 51. Global Dapagliflozin API Average Price by Region (2025-2030) & (US$/Kg)
    Table 52. Key Countries/Regions Dapagliflozin API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dapagliflozin API Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dapagliflozin API Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dapagliflozin API Sales Volume, (2019-2024) & (Kg)
    Table 56. Key Countries/Regions Dapagliflozin API Sales Volume, (2025-2030) & (Kg)
    Table 57. Sun Pharmaceutical Industries Ltd. Company Information
    Table 58. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 59. Sun Pharmaceutical Industries Ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 60. Sun Pharmaceutical Industries Ltd. Dapagliflozin API Product Offerings
    Table 61. Sun Pharmaceutical Industries Ltd. Recent Development
    Table 62. Metrochem API Pvt Ltd Company Information
    Table 63. Metrochem API Pvt Ltd Introduction and Business Overview
    Table 64. Metrochem API Pvt Ltd Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 65. Metrochem API Pvt Ltd Dapagliflozin API Product Offerings
    Table 66. Metrochem API Pvt Ltd Recent Development
    Table 67. Polpharma Company Information
    Table 68. Polpharma Introduction and Business Overview
    Table 69. Polpharma Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 70. Polpharma Dapagliflozin API Product Offerings
    Table 71. Polpharma Recent Development
    Table 72. Dr. Reddy’s Laboratories Ltd. Company Information
    Table 73. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
    Table 74. Dr. Reddy’s Laboratories Ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 75. Dr. Reddy’s Laboratories Ltd. Dapagliflozin API Product Offerings
    Table 76. Dr. Reddy’s Laboratories Ltd. Recent Development
    Table 77. CIC Company Information
    Table 78. CIC Introduction and Business Overview
    Table 79. CIC Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 80. CIC Dapagliflozin API Product Offerings
    Table 81. CIC Recent Development
    Table 82. Honour Lab Limited Company Information
    Table 83. Honour Lab Limited Introduction and Business Overview
    Table 84. Honour Lab Limited Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 85. Honour Lab Limited Dapagliflozin API Product Offerings
    Table 86. Honour Lab Limited Recent Development
    Table 87. SGMR Pharmaceuticals Pvt Ltd. Company Information
    Table 88. SGMR Pharmaceuticals Pvt Ltd. Introduction and Business Overview
    Table 89. SGMR Pharmaceuticals Pvt Ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 90. SGMR Pharmaceuticals Pvt Ltd. Dapagliflozin API Product Offerings
    Table 91. SGMR Pharmaceuticals Pvt Ltd. Recent Development
    Table 92. Kopran Company Information
    Table 93. Kopran Introduction and Business Overview
    Table 94. Kopran Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 95. Kopran Dapagliflozin API Product Offerings
    Table 96. Kopran Recent Development
    Table 97. Morepen Company Information
    Table 98. Morepen Introduction and Business Overview
    Table 99. Morepen Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 100. Morepen Dapagliflozin API Product Offerings
    Table 101. Morepen Recent Development
    Table 102. SKVen Technologies Pvt. Ltd Company Information
    Table 103. SKVen Technologies Pvt. Ltd Introduction and Business Overview
    Table 104. SKVen Technologies Pvt. Ltd Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 105. SKVen Technologies Pvt. Ltd Dapagliflozin API Product Offerings
    Table 106. SKVen Technologies Pvt. Ltd Recent Development
    Table 107. Danesh Kimia Pharmed Co. Company Information
    Table 108. Danesh Kimia Pharmed Co. Introduction and Business Overview
    Table 109. Danesh Kimia Pharmed Co. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 110. Danesh Kimia Pharmed Co. Dapagliflozin API Product Offerings
    Table 111. Danesh Kimia Pharmed Co. Recent Development
    Table 112. Boryung Pharmaceutical Company Information
    Table 113. Boryung Pharmaceutical Introduction and Business Overview
    Table 114. Boryung Pharmaceutical Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 115. Boryung Pharmaceutical Dapagliflozin API Product Offerings
    Table 116. Boryung Pharmaceutical Recent Development
    Table 117. Tecoland Company Information
    Table 118. Tecoland Introduction and Business Overview
    Table 119. Tecoland Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 120. Tecoland Dapagliflozin API Product Offerings
    Table 121. Tecoland Recent Development
    Table 122. Zhejiang Tuopu Pharmaceutical Co., Ltd. Company Information
    Table 123. Zhejiang Tuopu Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 124. Zhejiang Tuopu Pharmaceutical Co., Ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 125. Zhejiang Tuopu Pharmaceutical Co., Ltd. Dapagliflozin API Product Offerings
    Table 126. Zhejiang Tuopu Pharmaceutical Co., Ltd. Recent Development
    Table 127. Shanghai Haoyuan Chemexpress Co., Ltd. Company Information
    Table 128. Shanghai Haoyuan Chemexpress Co., Ltd. Introduction and Business Overview
    Table 129. Shanghai Haoyuan Chemexpress Co., Ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 130. Shanghai Haoyuan Chemexpress Co., Ltd. Dapagliflozin API Product Offerings
    Table 131. Shanghai Haoyuan Chemexpress Co., Ltd. Recent Development
    Table 132. Cangzhou Enke Pharma Tech Co.,ltd. Company Information
    Table 133. Cangzhou Enke Pharma Tech Co.,ltd. Introduction and Business Overview
    Table 134. Cangzhou Enke Pharma Tech Co.,ltd. Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 135. Cangzhou Enke Pharma Tech Co.,ltd. Dapagliflozin API Product Offerings
    Table 136. Cangzhou Enke Pharma Tech Co.,ltd. Recent Development
    Table 137. Beijing Ditai Medicine Technology Co., LTD Company Information
    Table 138. Beijing Ditai Medicine Technology Co., LTD Introduction and Business Overview
    Table 139. Beijing Ditai Medicine Technology Co., LTD Dapagliflozin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
    Table 140. Beijing Ditai Medicine Technology Co., LTD Dapagliflozin API Product Offerings
    Table 141. Beijing Ditai Medicine Technology Co., LTD Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Dapagliflozin API Downstream Customers
    Table 145. Dapagliflozin API Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dapagliflozin API Product Picture
    Figure 2. Global Dapagliflozin API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dapagliflozin API Sales Volume (2019-2030) & (Kg)
    Figure 5. Global Dapagliflozin API Sales Price (2019-2030) & (US$/Kg)
    Figure 6. Dapagliflozin API Report Years Considered
    Figure 7. Global Dapagliflozin API Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dapagliflozin API Players Sales Volume Ranking (2023) & (Kg)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dapagliflozin API Revenue in 2023
    Figure 10. Dapagliflozin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. ≥99.0% Picture
    Figure 12. ≥98.0% Picture
    Figure 13. Global Dapagliflozin API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Dapagliflozin API Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Dapagliflozin API Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)
    Figure 16. Global Dapagliflozin API Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Dapagliflozin API Price by Type (2019-2030) & (US$/Kg)
    Figure 18. Product Picture of Tablet
    Figure 19. Product Picture of Others
    Figure 20. Global Dapagliflozin API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Dapagliflozin API Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Dapagliflozin API Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)
    Figure 23. Global Dapagliflozin API Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Dapagliflozin API Price by Application (2019-2030) & (US$/Kg)
    Figure 25. North America Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Dapagliflozin API Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Dapagliflozin API Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Dapagliflozin API Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Dapagliflozin API Sales Volume (%), (2019-2030)
    Figure 37. United States Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Dapagliflozin API Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Dapagliflozin API Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Dapagliflozin API Sales Value by Application (%), 2023 VS 2030
    Figure 58. Dapagliflozin API Industrial Chain
    Figure 59. Dapagliflozin API Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart